Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 24 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 9242007

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  2. US 9243051

    Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  3. US 9238069

    Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  4. US 9234179

    Materials and methods for generating pluripotent stem cells

    SHANGHAI UNITED STEM CELL BIOTECHNOLOGY CO., LTD. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  5. US 9228007

    Recombinant human progenitor cells, engineered human thymocytes, and engineered human T cells

    The Regents of the University of California · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  6. US 9228171

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  7. US 9220706

    Inhibition of leukemic stem cells by PP2A activating agents

    THE UNITED STATES OF AMERICA NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  8. US 9217024

    ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

    Acumen Pharmaceuticals, Inc. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted

  9. US 9210925

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  10. US 9205276

    Light as a replacement for mitogenic factors on progenitor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND SERVICES · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  11. US 9192630

    Transplantation of neural cells

    The Regents of the University of California · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  12. US 9192629

    Isolated renal cells and uses thereof

    REGENMEDTX, LLC · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  13. US 9181231

    Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia

    Agios Pharmaceuticals, Inc. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  14. US 9175264

    Postnatal stem cells and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  15. US 9169495

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  16. US 9163215

    Generation of lineage-restricted progenitor cells from differentiated cells

    The Regents of the University of California · Granted Oct 20, 2015 · Expires Oct 15, 2035

    granted

  17. US 9157069

    Method of producing pancreatic hormone-producing cells

    Takeda Pharmaceutical Company Limited · Granted Oct 13, 2015 · Expires Oct 8, 2035

    granted

  18. US 9150831

    Conditionally immortalized long-term stem cells and methods of making and using such cells

    The Regents of the University of Colorado · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  19. US 9132152

    Compositions and methods for generating induced pluripotent stem cells

    The Regents of the University of California · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted

  20. US 9115371

    Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  21. US 9114116

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Northwestern University · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted

  22. US 9107897

    Methods for isolating mammalian retinal progenitor cells

    The Regents of the University of California · Granted Aug 18, 2015 · Expires Aug 13, 2035

    granted

  23. US 9095562

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  24. US 9085757

    Production of insulin producing cells

    Regents of the University of Minnesota · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.